Grant: Fellowship - PA: CIHR/Rx&D - CAMO Research Program
McMaster University
$27,500.00
Time to Initiation of Adjuvant Chemotherapy after Curative Surgical Resection of Colorectal Cancer at the Juravinski Cancer Centre
FY 2012-13
Summary
Colorectal cancer is one of the most common cancers diagnosed within the North America. An important advance in medical oncology has been the use of adjuvant chemotherapy for colorectal cancer. While surgical resection remains the cornerstone of management for patients with this disease, adjuvant chemotherapy is also routinely recommended postoperatively for high risk colorectal cancers. Survival with stage II and III colorectal cancers has improved with the addition of adjuvant chemotherapy as a component of treatment. Little is known about the significance of timing and early discontinuation of adjuvant treatment in such patients. There has been a dearth of research about the effect of the timing of chemotherapy on survival. Recent studies have shown a possible link between the length of time between surgery and chemotherapy treatment and probability of survival. However, the effect of the interval between surgery and the initiation of chemotherapy on survival (optimal time) has not been well documented. The aim of this research is to assess the time between curative surgical resection and initiation of adjuvant chemotherapy in patients with stage II and III colorectal cancers and explore potential causes of delay to the initiation of adjuvant chemotherapy at Juravinski Cancer Centre. The results obtain will ultimately improve time to initiation of adjuvant chemotherapy and therefore improve patients survival.
Department
Program
Fellowship - PA: CIHR/Rx&D - CAMO Research Program
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
272934
Name
Anjum Mahraz
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Partnername
Canadian Association of Medical Oncologists (Ottawa)
Instname2
Cancer Research
Theme2
Clinical
Prcname2
Health Research Training B - HP
Projecttitle
Time to Initiation of Adjuvant Chemotherapy after Curative Surgical Resection of Colorectal Cancer at the Juravinski Cancer Centre
Programtype2
Fellowship Programs
Orgnameinp2
McMaster University
Cihramount2
$27,500
Cihrequipment2
$0
Programname2
Fellowship - PA: CIHR/Rx&D - CAMO Research Program
Keyworddelim
Adjuvant Therapy; Cancer Therapy Delay; Colorectal Cancer; Survival
Abstract
Colorectal cancer is one of the most common cancers diagnosed within the North America. An important advance in medical oncology has been the use of adjuvant chemotherapy for colorectal cancer. While surgical resection remains the cornerstone of management for patients with this disease, adjuvant chemotherapy is also routinely recommended postoperatively for high risk colorectal cancers. Survival with stage II and III colorectal cancers has improved with the addition of adjuvant chemotherapy as a component of treatment. Little is known about the significance of timing and early discontinuation of adjuvant treatment in such patients. There has been a dearth of research about the effect of the timing of chemotherapy on survival. Recent studies have shown a possible link between the length of time between surgery and chemotherapy treatment and probability of survival. However, the effect of the interval between surgery and the initiation of chemotherapy on survival (optimal time) has not been well documented. The aim of this research is to assess the time between curative surgical resection and initiation of adjuvant chemotherapy in patients with stage II and III colorectal cancers and explore potential causes of delay to the initiation of adjuvant chemotherapy at Juravinski Cancer Centre. The results obtain will ultimately improve time to initiation of adjuvant chemotherapy and therefore improve patients survival.
Competitiondate
201210
Approvedterm2
1 yr 0 mth
Pinamesdelim
Anjum, Mahraz
Approvedterm
1 an 0 mois
Cihrcontribution2
Patient Oriented Research~ $27,500~ $0~